In a follow-up examination we queried the Oncomine Platform (www.oncomine.org) and we found data from other studies indicating a statistically significantly increased expression of DLGAP1 in myeloid malignancies in humans (Additional file 3), while the copy number of DLGAP1 in myeloid malignancies was not noticeably changed based on the available datasets (Additional file 3). This evidence concerns the gene DLGAP1 and myeloid neoplasm.